Moderna Inc. buy Ellritze
Start price
01.12.21
/
70%
€274.00
Target price
01.12.22
€260.00
Performance (%)
-15.33%
End price
12.12.21
€232.00
Summary
This prediction ended on 12.12.21 with a price of €232.00. The prediction for Moderna Inc. disappointed with a performance of -15.33%. Ellritze has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Moderna Inc. | 5.989% | 5.989% | -14.826% |
iShares Core DAX® | 2.594% | -1.158% | 14.782% |
iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% |
iShares Nikkei 225® | 0.687% | -8.354% | 18.454% |
iShares S&P 500 | 2.209% | -0.942% | 31.361% |
According to Ellritze what are the pros and cons of Moderna Inc. for the foreseeable future?
Pros
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Cons
Higher risks for its business
Below average Marketposition
Comments by Ellritze for this prediction
In the thread Moderna Inc. diskutieren
Buy mit Kursziel 310,0
Kursziel geändert auf 260,0
In the thread Trading Moderna Inc.
Buy beendet
Stopped prediction by Ellritze for Moderna Inc.
Moderna Inc.
Start price
Target price
Perf. (%)
€158.84
04.04.22
04.04.22
€178.00
04.04.23
04.04.23
-12.49%
19.04.22
19.04.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€162.42
21.03.22
21.03.22
€180.00
21.03.23
21.03.23
-2.20%
04.04.22
04.04.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€137.00
22.01.22
22.01.22
€165.00
22.01.23
22.01.23
4.37%
06.02.22
06.02.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€139.80
21.01.22
21.01.22
€160.00
21.01.23
21.01.23
-2.00%
22.01.22
22.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€224.75
25.12.21
25.12.21
€260.00
25.12.22
25.12.22
-14.41%
06.01.22
06.01.22
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Moderna Inc.
Start price
Target price
Perf. (%)
€232.00
12.12.21
12.12.21
€260.00
12.12.22
12.12.22
-3.13%
25.12.21
25.12.21
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business